Cargando…
Pluripotent Stem Cells in Clinical Setting—New Developments and Overview of Current Status
The number of clinical trials using human pluripotent stem cells (hPSC)—both embryonic and induced pluripotent stem cells (hESC/iPSC)—has expanded in the last several years beyond expectations. By the end of 2021, a total of 90 trials had been registered in 13 countries with more than 3000 participa...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512105/ https://www.ncbi.nlm.nih.gov/pubmed/35671338 http://dx.doi.org/10.1093/stmcls/sxac040 |